TissGeneSummary for TSGA10 |
Gene summary |
Basic gene information | Gene symbol | TSGA10 |
Gene name | testis specific, 10 | |
Synonyms | CEP4L|CT79 | |
Cytomap | UCSC genome browser: 2q11.2 | |
Type of gene | protein-coding | |
RefGenes | NM_025244.2, NM_182911.3, | |
Description | cancer/testis antigen 79testis development protein NYD-SP7testis-specific gene 10 protein | |
Modification date | 20141207 | |
dbXrefs | MIM : 607166 | |
HGNC : HGNC | ||
Ensembl : ENSG00000135951 | ||
HPRD : 06202 | ||
Vega : OTTHUMG00000130637 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TSGA10 | |
BioGPS: 80705 | ||
Pathway | NCI Pathway Interaction Database: TSGA10 | |
KEGG: TSGA10 | ||
REACTOME: TSGA10 | ||
Pathway Commons: TSGA10 | ||
Context | iHOP: TSGA10 | |
ligand binding site mutation search in PubMed: TSGA10 | ||
UCL Cancer Institute: TSGA10 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | ||
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of TSGA10 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for TSGA10 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | 0.065841907 | 1.263493907 | -1.197652 | 2.12E-07 | 9.11E-07 |
HNSC | -1.188115953 | -0.122483395 | -1.065632558 | 6.45E-07 | 5.11E-06 |
KIRC | -0.499408815 | 0.974924518 | -1.474333333 | 2.30E-19 | 1.70E-18 |
Top |
TissGene-miRNA for TSGA10 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for TSGA10 |
TissGeneSNV for TSGA10 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R33C | SKCM | 2 |
p.S286F | SKCM | 2 |
p.R113Q | SKCM | 1 |
p.Y695C | LUAD | 1 |
p.R33H | BRCA | 1 |
p.I50S | UCEC | 1 |
p.D460Y | LUAD | 1 |
p.D278G | HNSC | 1 |
p.E190* | KIRP | 1 |
p.H46N | UCEC | 1 |
p.R253Q | HNSC | 1 |
p.I258T | KIRC | 1 |
p.E647K | SKCM | 1 |
p.S59Y | UCEC | 1 |
p.K197N | ESCA | 1 |
p.R418* | UCEC | 1 |
p.Q479H | COAD | 1 |
p.A531V | COAD | 1 |
p.S290R | UCEC | 1 |
p.E145Q | BLCA | 1 |
p.E190X | KIRP | 1 |
p.E233D | THCA | 1 |
p.E535* | UCEC | 1 |
p.K279R | UCEC | 1 |
p.R77Q | UCEC | 1 |
p.N401D | LUAD | 1 |
p.T93M | PAAD | 1 |
p.Q495* | SKCM | 1 |
p.Q387E | LUAD | 1 |
p.R331W | CESC | 1 |
p.L445R | STAD | 1 |
p.S545Y | LUSC | 1 |
p.Q332* | UCEC | 1 |
p.R3* | PRAD | 1 |
p.E69K | KIRC | 1 |
p.V502L | HNSC | 1 |
p.L154P | ESCA | 1 |
p.N283K | UCEC | 1 |
p.I536T | BLCA | 1 |
p.R418X | SKCM | 1 |
p.I284S | UCEC | 1 |
p.R113* | LUAD | 1 |
p.V321A | OV | 1 |
p.E537* | UCEC | 1 |
p.R79Q | DLBC | 1 |
p.K477M | STAD | 1 |
p.R330C | UCEC | 1 |
p.S662Y | READ | 1 |
p.R3Q | COAD | 1 |
p.L273M | STAD | 1 |
p.Q495X | SKCM | 1 |
p.Q495H | COAD | 1 |
p.R687* | UCEC | 1 |
p.E255D | SKCM | 1 |
p.S372P | SKCM | 1 |
p.R687L | ESCA | 1 |
p.Q252E | HNSC | 1 |
p.A133V | STAD | 1 |
p.E551* | LUAD | 1 |
p.S6F | SKCM | 1 |
p.R432H | HNSC | 1 |
p.T262N | ESCA | 1 |
p.E69D | BLCA | 1 |
p.V487A | UCEC | 1 |
p.E148Q | CESC | 1 |
p.S202Y | UCEC | 1 |
p.T132A | LIHC | 1 |
p.R575Q | UCEC | 1 |
p.R3X | COAD | 1 |
p.S299L | SKCM | 1 |
p.R33C | UCEC | 1 |
p.E597K | GBM | 1 |
p.R561K | STAD | 1 |
p.R3X | PRAD | 1 |
p.R687* | SARC | 1 |
p.S461F | HNSC | 1 |
p.E136* | LUAD | 1 |
p.Q556* | LUAD | 1 |
p.K532* | SKCM | 1 |
p.L206F | LUSC | 1 |
p.R683Q | KIRP | 1 |
p.D460Y | PRAD | 1 |
p.E451D | PAAD | 1 |
p.E578Q | ESCA | 1 |
p.S13P | COAD | 1 |
p.P9L | SKCM | 1 |
p.K169E | HNSC | 1 |
p.E145Q | HNSC | 1 |
p.G288E | SKCM | 1 |
p.E691D | OV | 1 |
p.Q556H | CHOL | 1 |
p.Q593E | BLCA | 1 |
p.K84E | ESCA | 1 |
p.K223N | ESCA | 1 |
p.S503Y | LUAD | 1 |
p.K279N | UCEC | 1 |
p.E102D | LUAD | 1 |
p.S408F | UCEC | 1 |
p.Y658* | BRCA | 1 |
p.S85G | THYM | 1 |
p.S672L | SKCM | 1 |
p.R649H | UCEC | 1 |
p.A558T | STAD | 1 |
p.L685P | UCEC | 1 |
p.R418* | SKCM | 1 |
p.R330C | STAD | 1 |
p.Q556H | LUAD | 1 |
p.R3* | STAD | 1 |
Top |
TissGeneCNV for TSGA10 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for TSGA10 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | UCS | TCGA-N9-A4Q1-01A | CHIC2-TSGA10 | Out-of-Frame | chr4:54915121 | chr2:99614684 |
TCGAfusionPortal | PRADA | BRCA | TCGA-A8-A08L-01A | CHN1-TSGA10 | CDS-5UTR | Chr2:175869622 | Chr2:99734222 |
TCGAfusionPortal | PRADA | LUSC | TCGA-22-5492-01A | ACTR2-TSGA10 | In-frame | Chr2:65455091 | Chr2:99722160 |
TCGAfusionPortal | PRADA | PRAD | TCGA-KK-A8ID-01A | KIAA1310-TSGA10 | In-frame | Chr2:97278555 | Chr2:99720581 |
Top |
TissGeneNet for TSGA10 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for TSGA10 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for TSGA10 |
TissGeneDrug for TSGA10 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for TSGA10 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0005695 | Bladder Neoplasm | 1 | LHGDN |
umls:C0009375 | Colonic Neoplasms | 1 | LHGDN |
umls:C0023418 | leukemia | 1 | BeFree |
umls:C0023449 | Acute lymphocytic leukemia | 1 | BeFree |
umls:C0025202 | melanoma | 1 | LHGDN |
umls:C0033578 | Prostatic Neoplasms | 1 | LHGDN |
umls:C0085669 | Acute leukemia | 1 | BeFree |
umls:C0242596 | Neoplasm, Residual | 1 | BeFree |
umls:C0376544 | Hematopoietic Neoplasms | 1 | BeFree |
umls:C0919267 | ovarian neoplasm | 1 | LHGDN |
umls:C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | BeFree,LHGDN |
umls:C2239176 | Liver carcinoma | 1 | BeFree,LHGDN |